Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION, USP
| Report ID | 119581 |
| Drug Identification Number | 02245248 |
| Brand name | AMIODARONE HYDROCHLORIDE INJECTION |
| Common or Proper name | Amiodarone Hydrochloride for Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 mg/mL, MD Vial 3 mL |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-07-13 |
| Actual start date | |
| Estimated end date | 2020-08-21 |
| Actual end date | 2020-08-05 |
| Shortage status | Resolved |
| Updated date | 2020-08-06 |
| Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Amiodarone Hydrochloride for Injection, 50 mg/mL, MD Vial 3 mL are now available at all distribution centres effective today, August 5, 2020. Please note that this product will remain on allocation. Contract customers will receive 100% of their historical monthly average volumes. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-08-06 | English | Compare |
| v5 | 2020-08-05 | French | Compare |
| v4 | 2020-08-05 | English | Compare |
| v3 | 2020-07-14 | English | Compare |
| v2 | 2020-07-06 | French | Compare |
| v1 | 2020-07-06 | English | Compare |
Showing 1 to 6 of 6